Mary Kruczynski has had a very diversified business career spanning 45 years, working early on in the insurance industry, engineering and ultimately health care. She has devoted the past 25 years to the specialties of obstetrics and gynecology, otology and neurotology, oncology/hematology, gynecologic oncology and radiation oncology.
Mary’s broad-based general management experience in a variety of areas has helped her to develop a unique skill set and as such, is often tasked with the challenges left unmet by others. Mary’s responsibilities have included initiation and incorporation of several practices into one entity, office automation, establishment of internal protocols for charge capture and CPT code creation for reimbursement.
Mary currently serves as the Director of Policy Analysis for the Community Oncology Alliance (COA), where she reviews and comments on significant federally proposed legislation, as well as issues raised at the state level. Mary has been with COA since its inception and shares her knowledge on legislative matters, health care reform law, coordinated patient care models and oral oncolytics with cancer care delivery teams across the country. She has also mentored those physicians currently in an oncology fellowship program.
In addition to diverse management experience, Mary demonstrates expertise in national meeting planning and is instrumental in producing COA’s annual conferences. Mary’s proven fund raising and development efforts help to sustain the efforts of COA and the caregivers and patients it seeks to protect and support. Furthermore, Mary has been instrumental in the development and management of past and current data projects, including the Components of Care Project, Oral Oncolytics Access, Comparative Cost of Cancer Care Predicated Upon Site of Service, and Cost Drivers of Cancer Care. Mary has authored numerous articles relating to clinical and reimbursement issues and sits on the editorial board of a number of cancer related journals. She has served as the Director of Policy Analysis for the Community Oncology Alliance since its inception in 2003.